Navigation Links
Codexis Names Lori Giver VP Systems Biology
Date:3/31/2009

REDWOOD CITY, Calif., March 31 /PRNewswire/ -- Codexis, Inc. today announced Lori Giver, Ph.D., has been named to the new position of Vice President, Systems Biology for Codexis Bioindustrials. She is responsible for cellular engineering, molecular biology, and computational biology. Dr. Giver reports to David Anton, Ph.D., Vice President, Bioindustrials Research and Development.

Dr. Giver is a widely-respected researcher in the directed evolution of genes and proteins. She joined Codexis in 2002 from Maxygen, where she was responsible for biocatalyst discovery and development. At Codexis, she has held a series of scientific leadership roles ranging from Associate Director, Research & Development to her most recent position as Senior Director, Evolution Technology.

She received a bachelor's degree in molecular and cell biology from the University of California at Berkeley, and a Ph.D. in molecular, cell and developmental biology from Indiana University, Bloomington, where she focused on the directed evolution of nucleic acids with Dr. Andrew Ellington. Dr. Giver did post-doctoral research in directed evolution of proteins at the California Institute of Technology with advisor Dr. Frances Arnold, a pioneer in the field of directed evolution and biocatalysis.

"Lori Giver's contribution to the development of today's strong and broad Codexis technology platform has been invaluable," Dr. Anton said. "She is one of the original core team of scientists that built both our expertise in biocatalysis and our world-class reputation in this field. Her appointment recognizes the role that systems biology, in combination with biocatalysis, will play in finding solutions to the critical need for renewable fuels and future clean technology products. Lori's advancement to our senior scientific leadership team recognizes her strong personal and professional dedication to our company, to her colleagues, and to finding technology solutions to the major challenges facing our society."

Codexis, Inc. is a clean technology company. The company develops industrial biocatalysts, including enzymes and microbes. Codexis technology is used in the energy industry to enable next generation, non-food biofuels and by global pharmaceutical companies for cost-effective manufacturing of human therapeutics. Future commercial applications include carbon management, water treatment and chemical manufacturing. For more information, visit www.codexis.com.

Contact: Lyn Christenson, lyn.christenson@codexis.com, 650-421-8144 or Saskia Sidenfaden, ssidenfaden@mww.com, 212-827-3771.


'/>"/>
SOURCE Codexis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Codexis, Teva in Licensing Agreement Final
2. Codexis Names Vice President, Intellectual Property
3. Codexis, Arch Announce Expanded Collaboration
4. Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering
5. Codexis Names David Anton VP Bioindustrials R&D
6. Codexis Launches Codex(TM) MicroCyp Platform to Produce Drug Metabolites and Novel Lead Compounds
7. Rothwell, Wolf Elected to Codexis Board
8. Codexis Opens Singapore Laboratory
9. Bruce Pasternack Elected to Codexis Board
10. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
11. Codexis Appoints Singapore Laboratories Managing Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):